Literature DB >> 8033523

Development of a type 2 diabetes symptom checklist: a measure of symptom severity.

P A Grootenhuis1, F J Snoek, R J Heine, L M Bouter.   

Abstract

The aim of the present study was to develop a Type 2 diabetes symptom checklist for use in clinical and epidemiological research, which can measure differences in symptom severity between patients and detect changes over time within patients. Face and content validity of items and dimension structure were based on literature and experiences of diabetologists. Two Likert scales were used to measure symptom frequency and perceived burden. Reliability, responsiveness and validity were studied in 185 Type 2 diabetic patients. Factor-analysis confirmed the predesigned dimension structure with 34 items, distributed over 6 dimensions. The internal consistency with Cronbach alpha coefficients between 0.76 and 0.95 and test-retest reliability with Pearson product-moment correlation coefficients between 0.79 and 0.94 were satisfactory. The ability to detect change over time (responsiveness) was estimated in stable subjects, using sample size calculations. A minimal detectable mean change of 0.07-0.58 points in total score on the 10-point scale within a group of 100 subjects suggests an impressive responsiveness. Significant differences in symptom severity score were found between patients with different co-morbidity status and treatment modes, indicating satisfactory construct validity of the dimension structure. The Type 2 Diabetes Symptom Checklist was found to be a useful diabetes-specific symptom severity assessment method for clinical and epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033523     DOI: 10.1111/j.1464-5491.1994.tb00268.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  60 in total

1.  The Diabetes Symptom Self-Care Inventory: development and psychometric testing with Mexican Americans.

Authors:  Alexandra A García
Journal:  J Pain Symptom Manage       Date:  2011-01-28       Impact factor: 3.612

2.  Fatigue in women with type 2 diabetes.

Authors:  Cynthia Fritschi; Laurie Quinn; Eileen D Hacker; Sue M Penckofer; Edward Wang; Marquis Foreman; Carol E Ferrans
Journal:  Diabetes Educ       Date:  2012-06-19       Impact factor: 2.140

3.  Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening Study.

Authors:  Marcel C Adriaanse; Jacqueline M Dekker; Annemieke M W Spijkerman; Jos W R Twisk; Giel Nijpels; Henk M van der Ploeg; Robert J Heine; Frank J Snoek
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

4.  Napping is associated with increased risk of type 2 diabetes: the Guangzhou Biobank Cohort Study.

Authors:  Kin-Bong Hubert Lam; Chao Qiang Jiang; G Neil Thomas; Teresa Arora; Wei Sen Zhang; Shahrad Taheri; Peymané Adab; Tai Hing Lam; Kar Keung Cheng
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

5.  Effects of stress management and relaxation training on the relationship between diabetes symptoms and affect among Latinos.

Authors:  Julie Wagner; Stephen Armeli; Howard Tennen; Angela Bermudez-Millan; Rafael Pérez-Escamilla
Journal:  Psychol Health       Date:  2018-06-01

6.  Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design.

Authors:  Steven Shea; Justin Starren; Ruth S Weinstock; Paul E Knudson; Jeanne Teresi; Douglas Holmes; Walter Palmas; Lesley Field; Robin Goland; Catherine Tuck; George Hripcsak; Linnea Capps; David Liss
Journal:  J Am Med Inform Assoc       Date:  2002 Jan-Feb       Impact factor: 4.497

Review 7.  Emotional and quality-of-life aspects of diabetes management.

Authors:  William H Polonsky
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

8.  Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist.

Authors:  C Grootscholten; G Ligtenberg; R H W M Derksen; K M G Schreurs; J W de Glas-Vos; E C Hagen; A W L van den Wall Bake; T W J Huizinga; F H J van den Hoogen; M Bijl; J C van Houwelingen; F J Snoek; J H M Berden
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

9.  A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.

Authors:  Sanne G Swinnen; Marie-Paule Dain; Ronnie Aronson; Melanie Davies; Hertzel C Gerstein; Andreas F Pfeiffer; Frank J Snoek; J Hans Devries; Joost B Hoekstra; Frits Holleman
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 17.152

10.  Consensus report of the coalition for clinical research-self-monitoring of blood glucose.

Authors:  David C Klonoff; Richard Bergenstal; Lawrence Blonde; Suzanne Austin Boren; Timothy S Church; Jenifer Gaffaney; Lois Jovanovic; David M Kendall; Craig Kollman; Boris P Kovatchev; Claudia Leippert; David R Owens; William H Polonsky; Gérard Reach; Eric Renard; Michael C Riddell; Richard R Rubin; Oliver Schnell; Linda M Siminiero; Robert A Vigersky; Darrell M Wilson; Alison Okada Wollitzer
Journal:  J Diabetes Sci Technol       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.